Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$39.24$39.77
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.20% | 16.85% | 11.16% | 18.66% | 21.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.20% | 16.85% | 11.16% | 18.66% | 21.48% |
| Cost of Revenue | 29.37% | 27.92% | 30.58% | 29.95% | 25.09% |
| Gross Profit | 10.17% | 14.85% | 7.73% | 16.64% | 20.83% |
| SG&A Expenses | -7.00% | 1.42% | 5.31% | 9.97% | 14.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -19.89% | 164.90% | -115.17% | 751.03% | 245.50% |
| Total Operating Expenses | 13.25% | 18.34% | 20.72% | 15.10% | 15.10% |
| Operating Income | 13.14% | 15.37% | 1.51% | 22.73% | 28.90% |
| Income Before Tax | 13.31% | 27.21% | 6.72% | 12.03% | 25.18% |
| Income Tax Expenses | 16.59% | 31.69% | 11.53% | 16.21% | 29.54% |
| Earnings from Continuing Operations | 12.43% | 26.02% | 5.48% | 10.95% | 24.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.43% | 26.02% | 5.48% | 10.95% | 24.06% |
| EBIT | 13.14% | 15.37% | 1.51% | 22.73% | 28.90% |
| EBITDA | 13.83% | 17.36% | 5.27% | 24.37% | 28.63% |
| EPS Basic | 12.58% | 26.15% | 5.72% | 11.30% | 24.58% |
| Normalized Basic EPS | 19.40% | 22.96% | 4.75% | 21.90% | 26.30% |
| EPS Diluted | 12.56% | 26.22% | 5.85% | 11.45% | 24.77% |
| Normalized Diluted EPS | 19.42% | 23.06% | 4.87% | 22.03% | 26.42% |
| Average Basic Shares Outstanding | -0.15% | -0.11% | -0.24% | -0.33% | -0.42% |
| Average Diluted Shares Outstanding | -0.16% | -0.20% | -0.35% | -0.44% | -0.52% |
| Dividend Per Share | 7.26% | 10.74% | 10.74% | 18.93% | 18.93% |
| Payout Ratio | 0.00% | -0.11% | 0.11% | 0.06% | -0.04% |